Home > Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment.

Paris, Alvar and Lake, Luke and Joseph, Albert and Workman, Anna and Walton, Joseph and Hayton, Tom and Evangelou, Nikos and Lilleker, James B and Ayling, Ruth M and Nicholl, David and Noyce, Alastair J (2023) Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment. Practical Neurology, 23, (3), pp. 222-228. doi: 10.1136/pn-2022-003631.

External website: https://pn.bmj.com/content/early/2023/02/03/pn-202...

Recreational use of nitrous oxide (NO) has increased rapidly in recent years and is now the second most commonly used recreational drug among young people in the UK. There has been a corresponding rise in cases of nitrous oxide-induced subacute combined degeneration of the cord (NO-SACD), a pattern of myeloneuropathy usually associated with severe vitamin B deficiency. This can cause serious and permanent disability in young people but, if recognised early, may be effectively treated. All neurologists should be aware of NO-SACD and its treatment; however, there are currently no agreed guidelines. Based on our experience in East London, an area of high NO use, we provide practical advice on its recognition, investigation and treatment.


Item Type
Article
Publication Type
International, Open Access, Article
Drug Type
Inhalents and solvents
Intervention Type
Harm reduction
Date
2023
Identification #
doi: 10.1136/pn-2022-003631
Page Range
pp. 222-228
Volume
23
Number
3
EndNote

Repository Staff Only: item control page